Cargando…
Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells
Multidrug resistance (MDR) is one of conventional cancer chemotherapy’s limitations. Our group previously synthesized a series of quinoline-based compounds in an attempt to identify novel anticancer agents. With a molecular docking analysis, the novel compound 160a was predicted to target p-glycopro...
Autores principales: | Zhou, Yuanyuan, Chung, Po-yee, Ma, Jessica Yuen-wuen, Lam, Alfred King-yin, Law, Simon, Chan, Kwok-wah, Chan, Albert Sun-chi, Li, Xingshu, Lam, Kim-hung, Chui, Chung-hin, Tang, Johnny Cheuk-on |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955663/ https://www.ncbi.nlm.nih.gov/pubmed/31581572 http://dx.doi.org/10.3390/biology8040075 |
Ejemplares similares
-
Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma
por: Chan, Dessy, et al.
Publicado: (2018) -
Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE(2)
por: Pun, Ivan Ho Yuen, et al.
Publicado: (2017) -
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma
por: Chung, Po Yee, et al.
Publicado: (2018) -
The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of Lumican
por: Zhou, Yuanyuan, et al.
Publicado: (2022) -
Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance
por: Quan, Xingping, et al.
Publicado: (2019)